Position in PGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$538,611
+$129,231 QoQ
Shares Held
139,176
+42.1% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. PGEN ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in PGEN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $538,611 | 139,176 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $409,380 | 97,938 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $261,739 | 79,556 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $97,789 | 68,866 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $89,796 | 60,266 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $145,897 | 130,266 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $161,025 | 169,501 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $267,811 | 169,501 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $239,470 | 165,152 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $214,196 | 159,848 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $226,984 | 159,848 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $195,908 | 170,355 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $201,882 | 190,455 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $271,675 | 178,734 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $378,916 | 178,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $148,236 | 110,624 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $156,701 | 74,266 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $240,652 | 64,866 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $103,622 | 20,766 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $135,394 | 20,766 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $119,989 | 17,415 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $284,365 | 27,879 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $182,626 | 52,179 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $260,373 | 52,179 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $200,202 | 58,883 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||